Alta Sciences

JULY 5, 2023

How to Facilitate Your Ophthalmic Drug Development tchichekian Thu, 07/06/2023 - 01:11 HTML From Discovery to Market, We’ve Got You Covered. As a leading partner in ophthalmic drug development , Altasciences has an outstanding track record formulating, testing, and manufacturing ophthalmic products.

Drug Development 52

Drug Development Drugs Clinical Research Production 52

Conversations in Drug Development Trends

OCTOBER 24, 2023

While this is a small number of people in each rare disease patient community, the significant and continued growth of rare disease drug development is unsurprising given that there are over 10,000 rare diseases , with more being discovered every year.

Clinical Trials 52

Clinical Trials Disease Therapies Drug Development 52

Drug Discovery World

AUGUST 18, 2023

CorEvitas expands our clinical research business with highly complementary real-world evidence solutions, which is an increasingly important area and will help to enhance decision-making as well as the time and cost of drug development.” The transaction is expected to be slightly accretive in 2023 and deliver $0.03

Laboratories 130

Laboratories Clinical Research Regulations Therapies 130

PPD

FEBRUARY 22, 2023

These anecdotal struggles were highlighted in industry research conducted by PPD, the clinical research business of Thermo Fisher Scientific. In a survey of more than 150 global drug development leaders, more than a quarter (28%) cited lack of R&D funding as the top challenge facing their organization.

Biosimilars 52

Biosimilars Clinical Research Marketing Trials 52

LifeSciVC

JULY 11, 2023

The meeting brings together tens of thousands of physicians, scientists, patients, advocates, innovators, and those involved in oncology drug development from around the world in order to explore the latest advances in cancer treatment, clinical trials, and translational and clinical research.

Therapies 66

Therapies Trials Clinical Development Science 66

PPD

NOVEMBER 30, 2023

As we approach the end of 2023, it’s time to reflect on the past 12 months and how advances in drug development shaped the pharma and biotech industries. These shifts are a prelude to further change and progress in the clinical trial landscape in 2024. Five Predictions for the Drug Development Industry in 2024 1.

Clinical Trials 98

Clinical Trials Trials Clinical Research Drug Development 98

Alta Sciences

JULY 28, 2023

Listen to the audiobook >>> ​​​ Issue 33 — CNS Drug Development: Integrated Solutions Lessen Complexity Hear about the complexities of CNS drug development programs and how an integrated CRO/CDMO can help move your molecule seamlessly from one phase to the next. Listen to the audiobook >>> Image Social Media Promo-01.jpg

Science 52

Science Clinical Research Clinical Trials Drug Development 52

Conversations in Drug Development Trends

NOVEMBER 10, 2023

If you’re interested in learning more about pain therapeutics research, check out our pain expertise. The post 3 Considerations of the Patient Perspective from the 2023 Pain Therapeutics Summit appeared first on Worldwide Clinical Trials.

Clinical Trials 75

Clinical Trials Trials Compliance Doctors 75

Conversations in Drug Development Trends

JANUARY 24, 2024

However, clinical research around Fragile X is considerably robust, making the possibility of clinical trial participation a potential motivation for parents to choose to undergo genetic testing for their children. As of July 2023, the American Society of Cell + Gene Therapy stated there were 3,905 therapies in development.

Trials 75

Trials Disease Clinical Trials Clinical Research 75

Drug Discovery World

APRIL 29, 2024

It has encouraged cannabis-derived and cannabis-related drug teams to contact the relevant Center for Drug Evaluation and Research (CDER) review division and CDER’s Botanical Review Team (BRT) to answer questions related to their specific drug development programme. Taylor CL, Pruyn SA. Explor Med. 2023;4:813–21.

Research 147

Research FDA Production Drug Development 147

Drug Discovery World

NOVEMBER 8, 2023

Harnessing AI, researchers have significantly expedited the drug discovery process, achieving what traditionally takes years in just 30 days. This method not only promises more efficient drug development but could also revolutionise clinical research and accelerate trials. NY Post 20 March 2023.

Clinical Trials 182

Clinical Trials Trials Disease Medical Schools 182

Vial

MARCH 1, 2024

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). By geographical region, the global CRO services market in 2023 was dominated by North America. billion in 2023 attributable to its laboratory products and biopharma services segment (53.8%

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

PPD

JUNE 27, 2024

Our expertise in alopecia areata studies As of July 2023, there were more than 60 planned or ongoing clinical trials for alopecia areata, involving nearly 20 pharmaceutical or biotech organizations. CorEvitas will be deploying AA focus groups among physicians and patients to provide insights for pragmatic clinical trial designs.

Treatment 52

Treatment Clinical Trials Small Molecule Clinical Research 52

Conversations in Drug Development Trends

DECEMBER 7, 2023

However, despite their greater service capabilities, large CROs have hit an inflection point in the clinical landscape, leading to unexpected industry dynamics characterized by a rise in CROs that take a more personalized approach.

Clinical Trials 136

Clinical Trials Clinical Development Trials Pharmaceutical Companies 136

PPD

JUNE 22, 2023

If your company is struggling to hire qualified clinical research associates (CRAs), you’re not alone. A decade-long CRA talent shortage intensified as the COVID-19 pandemic increased strain on the clinical research industry at large. Climbing demand is driving the CRA talent gap.

Clinical Research 52

Clinical Research Clinical Trials Trials Drug Development 52

Vial

FEBRUARY 29, 2024

Contract research organizations (CROs) are an integral partner of the drug development process, as they play a pivotal role supporting clinical trial conduct for pharmaceutical, biotechnology, and medical device sponsor companies. between 2023 and 2032. By 2032, this value is expected to reach US$108 billion.

Clinical Trials 52

Clinical Trials Trials Clinical Research Marketing 52

Conversations in Drug Development Trends

FEBRUARY 22, 2023

What will have the greatest impact on rare disease patients in 2023? Katie Nichols, senior project manager at Worldwide Clinical Trials, has been dedicated to rare disease research for seven years, seeing the impact firsthand that the progression of rare disease research has on rare disease communities.

Disease 52

Disease Clinical Trials Trials Treatment 52

Vial

APRIL 10, 2024

The increasing costs associated with in-house drug development have prompted biotech and pharmaceutical companies to increasingly outsource to contract research organization s (CROs) for assistance. The company reported a revenue of $11,116 million for the first nine months of 2023, marking a 4.2%

Clinical Trials 52

Clinical Trials Trials Compliance Clinical Research 52

Alta Sciences

DECEMBER 14, 2023

A Closer Look At Our On-Site Compounding Pharmacies shajjar Thu, 12/14/2023 - 21:30 HTML Altasciences' dedicated pharmacists bring a wealth of expertise in controlled substances and complex compounding, ensuring maximum precision and safety standards. Electronic security access to the pharmacy and video monitoring. -

Compounding Pharmacies 40

Compounding Pharmacies Pharmacy Clinical Pharmacology Clinical Supply 40

PPD

NOVEMBER 14, 2023

Clinical research requires vast talent across a variety of roles and specialties, as well as across global locations. In this complex environment, functional service partnership (FSP) models have become a solution of choice for pharmaceutical and biotech companies navigating the challenges of clinical development.

Clinical Research 52

Clinical Research Clinical Development International Engineering 52

PPD

OCTOBER 18, 2023

Continued expansion of the biotech industry is occurring in parallel, with an estimated compound annual growth rate of 13.96% from 2023-2030. 1 With this growth comes increased demands for laboratory services at all steps across the development process.

Laboratories 52

Laboratories Assay Development Small Molecule Packaging 52

PPD

OCTOBER 31, 2023

If recruitment moves slowly or individuals with the wrong skills are selected, the clinical research process stalls, costing sponsors valuable time, money and resources. Selecting the Right Partnership Model Clinical research outsourcing models have changed over time to accommodate the industry’s evolving needs.

International 52

International Clinical Research Clinical Development Research 52

PPD

NOVEMBER 7, 2023

The underrepresentation of diverse groups in clinical research is an area of regulatory, scientific and industry focus, partly due to the recent U.S. Food and Drug Administration (FDA) draft guidance, “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials.”

Clinical Trials 59

Clinical Trials Trials Clinical Research Disease 59

Drug Discovery World

OCTOBER 16, 2023

From the Beatson Institute for Cancer Research in Glasgow, to Edinburgh Drug Discovery in the University of Edinburgh’s Institute for Genetics and Cancer (IGC). At ELRIG’s Scottish Research and Drug Development Forum meeting, DDW’s Diana Spencer provided a snapshot of drug discovery in Scotland.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

Alta Sciences

SEPTEMBER 13, 2023

Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials pmjackson Wed, 09/13/2023 - 17:01 September is pain awareness month, and the importance of pain management and continued research into effective analgesics is integral to helping patients suffering from various pain conditions.

Clinical Trials 52

Clinical Trials Treatment Trials Drug Development 52

PPD

JULY 13, 2023

Their services help engage a suitable participant pool, facilitate clinical trial participation, ensure that selected sites have the resources to support clinical trial activities and more. Patient education programs and resources can help inform potential participants of the critical role they can play in clinical research.

Pharma Companies 52

Pharma Companies Clinical Trials Trials Clinical Research 52

Vial

FEBRUARY 15, 2024

Sponsors often contract a CRO to delegate specific day-to-day tasks, streamlining their research processes and enhancing efficiency. Conclusion As the global clinical trials outsourcing market continues to expand, CROs are increasingly recognized as essential partners in the drug development ecosystem.

Pharma Companies 52

Pharma Companies Clinical Trials Compliance Trials 52

PPD

MARCH 28, 2024

The biotech index (XBI) has already shown promising signs as well, having bottomed out mid-2023 and steadily building a base since then. This trend indicates that market participants view many public companies as attractive bargains, boosting the availability of follow-on offerings and PIPEs for additional funding opportunities.

Trials 52

Trials Clinical Trials Drug Development Clinical Research 52

Alta Sciences

JULY 18, 2023

Top 10 Life Science Resources pmjackson Tue, 07/18/2023 - 19:01 There’s a lot of life science content out there, which is why we’ve curated a selection of our expert insights, tips, case studies, and scientific and regulatory information for you. There are several reasons why choosing Canada for your clinical trials can be beneficial.

Science 40

Science Clinical Trials FDA Trials 40

Vial

FEBRUARY 26, 2024

The pharmaceutical and biotechnological landscape is constantly evolving and a key partner within the drug development process is contract research organizations (CROs) , who are at the forefront with sponsors to drive innovation in clinical research.

Clinical Trials 52

Clinical Trials Trials Clinical Research Pharmaceuticals 52

Conversations in Drug Development Trends

NOVEMBER 27, 2023

In June 2023, the U.S. Food and Drug Administration (FDA) announced its acceptance of the Biologics License Application (BLA) for exa-cel. In recognition of the unmet need and medical urgency for innovative therapies in the sickle cell space, the FDA granted exa-cel Priority Review, with a formal decision expected by December 8, 2023.

Treatment 75

Treatment FDA Clinical Trials Therapies 75

Drug Discovery World

AUGUST 3, 2023

With this in mind, the FDA claims to be committed to sound scientific research into the area and has a number of processes in place for those in the medical research community who intend to study cannabis 1.

Clinical Trials 130

Clinical Trials Regulations Production FDA 130

The Premier Consulting Blog

JUNE 18, 2023

This has opened new opportunities in pharmaceutical drug development, such as the ability to evaluate large complex databases and to integrate information in useful ways. One exciting application of these technologies is the use of in silico trials in the development of novel therapies for rare diseases.

Drug Development 52

Drug Development Disease Clinical Trials Drugs 52

Vial

MARCH 27, 2024

Increasing Demand for Contract Research Organization (CRO) Support CROs are pivotal to the successful execution of clinical trials, offering a tailored resource of expertise, services, and logistical support that can significantly streamline the process for sponsors. from 2024 to 2030.

Clinical Trials 52

Clinical Trials Trials International Compliance 52

Agency IQ

MARCH 1, 2024

12/29/2023 FDORA, Section 2512 Shortages : FDA must review its policies related to drug or biologic expiration dates and issue draft guidance or revise existing guidance on stability testing data in drug and biological product submissions.

FDA 40

FDA Science Clinical Trials Regulations 40

Drug Discovery World

OCTOBER 20, 2022

CELLINK Corporation, the Japanese subsidiary, was established in 2020 in Kansai, a region renowned for life sciences research facilities and corporations 3. . The post A review of Japan’s drug discovery and development landscape appeared first on Drug Discovery World (DDW). References . link] ). .

Drugs 130

Drugs International Science Government 130

Agency IQ

FEBRUARY 12, 2024

The consortium is funded by a public-private partnership called the Accelerating Medicines Partnership (AMP) , through which the Foundation for the NIH (FNIH) administers funds provided by industry, government, and nonprofits to scientists working on applicable basic or clinical research to advance gene therapy development for rare diseases.

FDA 40

FDA Therapies Clinical Trials Virus 40